Biogen (BIIB) 获得花旗银行的持有评级
According to TipRanks, Meacham is a 4-star analyst with an average return of 4.2% and a 55.14% success rate. Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals. In addition to Citi, Biogen also received a Hold from Morgan Stanley’s Terence Flynn in a report issued on October 10. However, on October 8, RBC Capital maintained a Buy rating on Biogen (NASDAQ: BIIB).
According to TipRanks, Meacham is a 4-star analyst with an average return of 4.2% and a 55.14% success rate. Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals.
In addition to Citi, Biogen also received a Hold from Morgan Stanley’s Terence Flynn in a report issued on October 10. However, on October 8, RBC Capital maintained a Buy rating on Biogen (NASDAQ: BIIB).
